Background: Portal vein thrombosis (PVT) is increasingly frequently being diagnosed, but systematic descriptions of the natural history and clinical handling of the condition are sparse.
Two-year follow-up data from 34 subjects in the VenoValve pivotal trial show sustained clinical improvement and continued patient benefit, from 12 months to 24 months.78% of subjects maintained a ...
Correspondence to Professor Changqing Yang, Division of Gastroenterology and Hepatology, Tongji Hospital, Tongji University School of Medicine, Shanghai, 389 XinCun Road, Shanghai 200065, China; ...